Elevated phospholipase D isoform 1 in Alzheimer's disease patients' hippocampus: Relevance to synaptic dysfunction and memory deficits

Balaji Krishnan1, Rakez Kayed1, Giulio Taglialatela1
1UTMB Mitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, USA

Tóm tắt

AbstractIntroductionPhospholipase D (PLD), a lipolytic enzyme that breaks down membrane phospholipids, is also involved in signaling mechanisms downstream of seven transmembrane receptors. Abnormally elevated levels of PLD activity are well‐established in Alzheimer's disease (AD), implicating the two isoforms of mammalian phosphatidylcholine cleaving PLD (PC‐PLD1 and PC‐PLD2). Therefore, we took a systematic approach of investigating isoform‐specific expression in human synaptosomes and further investigated the possibility of therapeutic intervention using preclinical studies.MethodsSynaptosomal Western blot analyses on the postmortem human hippocampus, temporal cortex, and frontal cortex of AD patient brains/age‐matched controls and the 3XTg‐AD mice hippocampus (mouse model with overexpression of human amyloid precursor protein, presenilin‐1 gene, and microtubule‐associated protein tau causing neuropathology progressing comparable to that in human AD patients) were used to detect the levels of neuronal PLD1 expression. Mouse hippocampal long‐term potentiation of PLD1‐dependent changes was studied using pharmacological approaches in ex vivo slice preparations from wild‐type and transgenic mouse models. Finally, PLD1‐dependent changes in novel object recognition memory were assessed following PLD1 inhibition.ResultsWe observed elevated synaptosomal PLD1 in the hippocampus/temporal cortex from postmortem tissues of AD patients compared to age‐matched controls and age‐dependent hippocampal PLD1 increases in 3XTg‐AD mice. PLD1 inhibition blocked effects of oligomeric amyloid β or toxic oligomeric tau species on high‐frequency stimulation long‐term potentiation and novel object recognition deficits in wild‐type mice. Finally, PLD1 inhibition blocked long‐term potentiation deficits normally observed in aging 3XTg‐AD mice.DiscussionUsing human studies, we propose a novel role for PLD1‐dependent signaling as a critical mechanism underlying oligomer‐driven synaptic dysfunction and consequent memory disruption in AD. We, further, provide the first set of preclinical studies toward future therapeutics targeting PLD1 in slowing down/stopping the progression of AD‐related memory deficits as a complementary approach to immunoscavenging clinical trials that are currently in progress.

Tài liệu tham khảo

10.1016/j.jalz.2017.02.001 10.15252/emmm.201606210 10.1038/nrneurol.2015.225 10.1016/j.neurobiolaging.2013.10.085 10.1155/2016/3245935 10.1007/s00401-009-0536-x 10.3233/JAD-130920 10.1038/nrd.2016.252 10.1194/jlr.R059220 10.1016/j.tips.2015.01.001 10.1016/j.nlm.2015.12.009 10.1371/journal.pone.0025639 Krishnan B., 2016, Amygdala‐hippocampal Phospholipase D (PLD) signaling as novel mechanism of cocaine‐environment maladaptive conditioned responses, Int J Neuropsychopharmacol, 19, pyv139, 10.1093/ijnp/pyv139 10.1016/0929-7855(96)00545-7 10.1523/JNEUROSCI.3317-10.2010 10.1073/pnas.0510708103 10.1073/pnas.0510710103 10.1016/j.neurobiolaging.2006.05.022 10.1016/S0896-6273(03)00434-3 10.1007/BF00308809 10.1016/0197-4580(94)90032-9 10.1016/j.jneumeth.2016.01.006 Garber J.C., 2011, Guide for the Care and Use of Laboratory Animals 10.1002/jnr.22445 10.1007/978-1-4939-6598-4_9 10.1007/978-1-4939-1096-0_14 Comerota M.M., 2017, Near infrared light decreases synaptic vulnerability to amyloid beta oligomers, Sci Rep, 7, 15012, 10.1038/s41598-017-15357-x 10.1111/j.1471-4159.2011.07576.x 10.1016/j.bbr.2008.12.034 Clark W.G., 1968, Accurate freehand injection into the lateral brain ventricle of the conscious mouse, J Appl Physiol, 25, 319, 10.1152/jappl.1968.25.3.319 10.1093/brain/awv236 10.1016/j.bbr.2015.04.012 10.1016/j.nbd.2007.06.013 10.1111/j.1471-4159.2005.03315.x 10.1016/j.neulet.2014.04.052 10.1016/j.neulet.2006.08.062 10.1038/srep19393 10.1073/pnas.261358698 Small D.H., 2004, Mechanisms of synaptic homeostasis in Alzheimer's disease, Curr Alzheimer Res, 1, 27, 10.2174/1567205043480573 10.1016/j.molmed.2007.12.006 10.1523/JNEUROSCI.5378-11.2012 10.1038/s41598-017-06121-2 10.1159/000354233 10.1111/jnc.12383 10.1091/mbc.11.12.4359 10.1038/srep14778 10.1038/sj.emboj.7601852 10.1016/j.bbalip.2009.04.008